Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J. physiol. biochem ; 73(2): 187-198, mayo 2017. graf, tab, ilus
Artículo en Inglés | IBECS | ID: ibc-168475

RESUMEN

The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect (AU)


No disponible


Asunto(s)
Animales , Ratas , Trastorno Autístico/prevención & control , Antiinflamatorios no Esteroideos/uso terapéutico , Ácido alfa-Linolénico/uso terapéutico , Modelos Animales de Enfermedad , Suplementos Dietéticos/efectos adversos , Ácido gammalinolénico/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Anticonvulsivantes/toxicidad , Antimaníacos/toxicidad , Conducta Animal , Ácido Valproico/toxicidad , Ubiquitina Tiolesterasa/metabolismo , Estrés Oxidativo , Biomarcadores , Ratas Wistar , Proteínas del Tejido Nervioso/metabolismo
2.
J Physiol Biochem ; 73(2): 187-198, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27878518

RESUMEN

The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Trastorno Autístico/prevención & control , Suplementos Dietéticos , Modelos Animales de Enfermedad , Fármacos Neuroprotectores/uso terapéutico , Ácido alfa-Linolénico/uso terapéutico , Ácido gammalinolénico/uso terapéutico , Animales , Animales Recién Nacidos , Antiinflamatorios no Esteroideos/efectos adversos , Anticonvulsivantes/toxicidad , Antimaníacos/toxicidad , Trastorno Autístico/inducido químicamente , Trastorno Autístico/inmunología , Trastorno Autístico/patología , Conducta Animal/efectos de los fármacos , Biomarcadores/sangre , Biomarcadores/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/inmunología , Encéfalo/metabolismo , Encéfalo/patología , Suplementos Dietéticos/efectos adversos , Mediadores de Inflamación/sangre , Mediadores de Inflamación/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Neuronas/efectos de los fármacos , Neuronas/inmunología , Neuronas/metabolismo , Neuronas/patología , Fármacos Neuroprotectores/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Ubiquitina Tiolesterasa/metabolismo , Ácido Valproico/toxicidad , Ácido alfa-Linolénico/efectos adversos , Ácido alfa-Linolénico/sangre , Ácido alfa-Linolénico/metabolismo , Ácido gammalinolénico/efectos adversos , Ácido gammalinolénico/sangre , Ácido gammalinolénico/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA